Issue 10, 2003

The spin-states and spin-crossover behaviour of iron(ii) complexes of 2,6-dipyrazol-1-ylpyrazine derivatives

Abstract

The syntheses of [FeL2]X2 (L = 2,6-dipyrazol-1-ylpyrazine [L2H], 2,6-bis{3-methylpyrazol-1-yl}pyrazine [L2Me], 2,6-bis{3,5-dimethylpyrazol-1-yl}pyrazine [L2Me2] or 2,6-bis{3-[2,4,6-trimethylphenyl]pyrazol-1-yl}pyrazine [L2Mes]; X = BF4 or ClO4) are described. Solvent-free [Fe(L2H)2][BF4]2 and [Fe(L2H)2][ClO4]2 exhibit very similar abrupt spin-state transitions at 223 K and 208 K respectively, which show hysteresis loops of 3–5 K. Powder diffraction measurements afforded related, but not identical, unit cells for these two compounds, and imply that [Fe(L2H)2][ClO4]2 is isomorphous with [Fe(L1H)2][BF4]2 (L1H = 2,6-dipyrazol-1-ylpyridine). The single crystalline solvate [Fe(L2H)2][BF4]2·3CH3NO2 undergoes a similarly abrupt spin-state transition at 198 K. Polycrystalline [Fe(L2Me)2][BF4]2 and [Fe(L2Me)2][ClO4]2 are isomorphous with each other and also exhibit spin-state transitions at low temperature, although these are very different in form. In contrast, both salts of [Fe(L2Me2)2]2+ and [Fe(L2Mes)2]2+ are fully low-spin at 295 K. Single crystal structures of [Fe(L2Me2)2][BF4]2·0.5{CH3}2CO·0.1H2O and [Fe(L2Mes)2][BF4]2·5CH3NO2 show low-spin complex dications, and imply that [Fe(L2Me2)2][BF4]2 is low-spin as a result of intra-ligand steric repulsions involving the pyrazole 5-methyl substituents. NMR and UV/vis data in MeCN and MeNO2 show that the spin states of all four complex dications are similar in solution and the solid state except for [Fe(L2Me2)2]2+, which exists as a mixture of high- and low-spin species in these solvents.

Graphical abstract: The spin-states and spin-crossover behaviour of iron(ii) complexes of 2,6-dipyrazol-1-ylpyrazine derivatives

Supplementary files

Article information

Article type
Paper
Submitted
22 Oct 2002
Accepted
06 Jan 2003
First published
23 Apr 2003

Dalton Trans., 2003, 2053-2060

The spin-states and spin-crossover behaviour of iron(II) complexes of 2,6-dipyrazol-1-ylpyrazine derivatives

J. Elhaïk, V. A. Money, S. A. Barrett, C. A. Kilner, I. R. Evans and M. A. Halcrow, Dalton Trans., 2003, 2053 DOI: 10.1039/B210368K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements